AntiHelix, a new training tool for young researchers

The AntiHelix project website is online

Helicases are molecular machines able to unwind double helices and other nucleic acids structures, and are thus implicated in all the cell mechanisms that involve DNA and RNA. Due to their importance in the cell, they are emerging as a new class of antibacterial, antiviral and ant-cancer drug targets.
The AntiHelix consortium (funded by the H2020-MSCA-ITN programme) includes academic and industrial partners with the aim of training young researchers, able to use a wide range of interdisciplinary approaches (cell bilogy, biochemistry, molecular biology, structural biology, single molecule techniques, structure-based drug design, clinical oncology) for the characterisation of the structure and function of medically relevant human helicases, to design novel inhibitors as putative drugs against cancer.



Last Updated on Tuesday, 05 November 2019 17:00